Parallax Volatility Advisers, L.P. Insmed Inc Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $12.3 Million - $15.7 Million	-198,900 Reduced 38.05%	323,800 $23.6 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $10.9 Million - $34.7 Million	497,700 Added 1990.8%	522,700 $35 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $131,172 - $152,694	-5,100 Reduced 16.94%	25,000 $678,000
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $704,942 - $955,374	30,100 New	30,100 $932,000
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $754,000 - $1.22 Million	-65,000 Reduced 92.86%	5,000 $66,000
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $947,500 - $1.4 Million	50,000 Added 250.0%	70,000 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $400,000 - $594,400	20,000 New	20,000 $473,000

466

180M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.56B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.